Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific's Applied Biosystems QuantStudio 3 and QuantStudio 5

Thermo Fisher Scientific has launched the Applied Biosystems QuantStudio 3 and QuantStudio 5, real-time PCR systems that fully integrate with cloud computing technology. The systems are designed for low- to mid-throughput laboratories conducting real-time PCR experiments, and are the first to connect to the Thermo Fisher Cloud computing platform, allowing geographically dispersed researchers to collaborate online in real time and access their data wherever and whenever necessary. Laboratories can also share experimental conditions and results with their partners, provide a uniform experience for every user, and help minimize training and errors. The new instruments integrate with existing analysis workflows including next-generation sequencing, capillary electrophoresis, and qPCR applications. Interactive touch-screen controls allow scientists to directly manage experiments with intuitive commands. As with the existing QuantStudio 6, 7, and 12K Flex instruments, the 3 and 5 include the Thermo Scientific OptiFlex white LED optical system and VeriFlex thermal technology.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.